MAR 15, 2018 6:59 PM PDT

Cannabis compound shows promise for severe epilepsy

WRITTEN BY: Invisiverse

For the first time, a form of medicinal cannabis has been shown to reduce—and even stop—seizures in some children with a severe form of epilepsy.

The children suffer from Dravet syndrome, a severe epilepsy that begins in infancy with drug-resistant seizures and a high mortality rate.

The seizures of five percent of the children stopped after they were treated with cannabidiol, a non-psychoactive form of cannabis. Overall, 43 percent of children with the syndrome had a 50 percent reduction in seizure frequency.

Known as CBD, cannabidiol is a natural compound found in cannabis seeds, stalks, and flowers that does not have the psychoactive properties of tetrahydrocannabinol, or THC.

“It’s the first scientific evidence that cannabidiol works,” says Ingrid Scheffer, professor of pediatric neurology at the University of Melbourne. “There have been anecdotal reports in the past, and people with firm beliefs that it works in epilepsy, but this is the first time it’s been proven.”

For the study, published in the New England Journal of Medicine, 120 children and young adults across the US and Europe received cannabidiol or a placebo, in addition to standard anti-epileptic treatment. The research took place as part of the Cannabidiol in Dravet Syndrome Study Group, and was a randomized, double-blind, and placebo-controlled trial.

Researchers measured seizure frequency over a 14-week treatment period. The findings show that the average frequency of convulsive seizures per month decreased from 12.4 to 5.9 among those children on cannabidiol, compared with a decrease from 14.9 to 14.1 among those on the placebo.

“I am delighted that we finally have high-level evidence that cannabidiol is effective for uncontrolled seizures in Dravet syndrome,” Scheffer says.

“If you can render any child or adult seizure free, that’s huge. It could contribute to stopping any further deterioration, or help development in a positive sense.”

Researchers asked caregivers to fill out the Global Impression of Change questionnaire—a seven-category system rating the scale of change in a patient. The results show that the patient’s overall condition improved by at least one category in 62 percent of the cannabidiol group, compared with only 34 percent of the placebo group.

Although the frequency of total seizures of all types was significantly reduced with cannabidiol, there was no significant reduction in non-convulsive seizures. But five percent of patients taking cannabidiol became seizure-free, compared with none of the placebo group.

“Many people who take part in trials like this are desperate to try something new. They’ve exhausted other options,” Scheffer says. “Five percent seizure-free is not 100 percent or 75 percent, but it’s reassuring to see that improvement. For these 5 percent of kids in the trial, it’s huge.

“Sadly this is not a panacea; it’s not going to cure these children. But it does give cause to be optimistic about further research for its use. It also raises a lot of questions, not just in terms of the treatment of epilepsy, but where else it could be applied medicinally. Cannabidiol is likely to be an important addition to our group of anti-epileptic tools.

There is a downside to the findings: side effects were more frequent in the cannabidiol group,  including diarrhea, vomiting, fatigue, decreased appetite, increased body temperature, drowsiness. and abnormal liver-function tests.

Worldwide, it’s estimated that around 1 percent of the population has epilepsy—about 65 million people globally. Dravet syndrome is a rare, catastrophic, lifelong form of epilepsy that begins in infancy. Previously known as Severe Myoclonic Epilepsy of Infancy (SMEI), it affects around 1 in almost 16,000 people.

Current treatment options are limited, and the associated seizures are particularly difficult because they are frequent, unpredictable, life-threatening, and not controlled by many anti-epileptic drugs.

“The next question is whether cannabidiol is effective in other forms of epilepsy,” Scheffer says. “It is great that there are trials already underway of cannabidiol in other groups of patients with epilepsy.”

 

This article was originally posted on futurity.org

About the Author
You May Also Like
SEP 01, 2021
Health & Medicine
Does Regular Cannabis Affect Brain Function? Sometimes in a Good Way
SEP 01, 2021
Does Regular Cannabis Affect Brain Function? Sometimes in a Good Way
With cannabis now legal in many parts of the world, an increasing number of people now count as regular users of the dru ...
SEP 06, 2021
Genetics & Genomics
How a Genetic Mutation Could Lead to Leaky Gut
SEP 06, 2021
How a Genetic Mutation Could Lead to Leaky Gut
In our gut, there is a vast community of microorganisms. It's crucial that they stay there in the gastrointestinal tract ...
SEP 16, 2021
Cancer
Inspiring Hope during Childhood Cancer Awareness Month
SEP 16, 2021
Inspiring Hope during Childhood Cancer Awareness Month
Childhood cancers, also known as pediatric cancers, are diagnosed in patients up to 14 years old.  Estimates for 20 ...
SEP 08, 2021
Health & Medicine
Intimate Partner Violence and COVID-19, A Crisis Behind Closed Doors
SEP 08, 2021
Intimate Partner Violence and COVID-19, A Crisis Behind Closed Doors
Intimate Partner Violence (IPV) is a significant issue in the United States and abroad. According to the CDC, the term & ...
SEP 08, 2021
Plants & Animals
Are the skeletons of macaque hybrids distinct?
SEP 08, 2021
Are the skeletons of macaque hybrids distinct?
New research sheds insight into the evolution of the human pelvis by using macaque hybrid models.
SEP 14, 2021
Technology
Dental Implant Produces Its Own Electricity And Fights Bacteria
SEP 14, 2021
Dental Implant Produces Its Own Electricity And Fights Bacteria
The use of dental implants offers a long term, effective treatment approach for lost or missing teeth compared to method ...
Loading Comments...